Phase 2 Pediatric Cancer Clinical Trials
10 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–10 of 10 trials
Recruiting
Phase 2
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
CancerPediatric CancerDifferentiated Thyroid Cancer+1 more
Children's Hospital of Philadelphia13 enrolled4 locationsNCT06458036
Recruiting
Phase 1Phase 2
Lurbinectedin in FET-Fused Tumors
Ewing SarcomaPediatric CancerDesmoplastic Small Round Cell Tumor+1 more
Children's Hospital of Philadelphia63 enrolled6 locationsNCT05918640
Recruiting
Phase 1Phase 2
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Hepatocellular CarcinomaRefractory Solid TumorPediatric Solid Tumor+3 more
St. Jude Children's Research Hospital64 enrolled2 locationsNCT05468359
Recruiting
Phase 2
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
Pediatric Cancer
Wake Forest University Health Sciences64 enrolled1 locationNCT04948619
Recruiting
Phase 1Phase 2
European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors
Pediatric Cancer
Gustave Roussy, Cancer Campus, Grand Paris472 enrolled21 locationsNCT02813135
Recruiting
Phase 2
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
CancerPediatric CancerDifferentiated Thyroid Cancer+1 more
Children's Hospital of Philadelphia13 enrolled5 locationsNCT05783323
Recruiting
Phase 2Phase 3
Cardiorespiratory Fitness in Children and Adolescents After Cancer Treatment.
All Types of Pediatric Cancer
Universität Duisburg-Essen56 enrolled1 locationNCT04765020
Recruiting
Phase 1Phase 2
Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen
Pediatric CancerRhabdomyosarcoma
Sun Yat-sen University82 enrolled1 locationNCT06456892
Recruiting
Phase 2
Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer
Li-Fraumeni SyndromePediatric Cancerp53 Mutations
Yang Li50 enrolled1 locationNCT06088030
Recruiting
Phase 1Phase 2
Radiotherapy Delivery in Deep Inspiration for Pediatric Patients
Pediatric Cancer
Rigshospitalet, Denmark25 enrolled3 locationsNCT03315546